Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 226

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 226
---
 prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by Yorkville, including with respect to
any compensation paid or payable by Yorkville to any brokers, dealers, underwriters or agents that participate in the distribution of
such shares by Yorkville, and any other related information required to be disclosed under the Securities Act.

We will pay the expenses incident
to the registration under the Securities Act of the offer and sale of the shares of our common stock covered by this prospectus by Yorkville.

As consideration for its irrevocable
commitment to purchase our common stock at our direction under the SEPA, we have agreed to (i) issue to Yorkville 131,909 shares
of our common stock as Commitment Shares, which Commitment Shares have a total aggregate value equal to 1% of Yorkville’s $20.0
million total dollar amount purchase commitment under the SEPA (assuming a value of $1.5162 per Commitment Share, representing the official
closing price of the common stock on the Nasdaq immediately preceding the execution of the SEPA), upon execution of the SEPA and the Registration
Rights Agreement and (ii) prior to the Commencement Date, pay Yorkville a structuring fee in the amount of $25,000, which is equal to
0.25% of Yorkville’s $20.0 million total dollar amount purchase commitment under the SEPA.

We also have agreed to indemnify
Yorkville and certain other persons against certain liabilities in connection with the offering of shares of our common stock offered
hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to
be paid in respect of such liabilities. Yorkville has agreed to indemnify us against liabilities under the Securities Act that may arise
from certain written information furnished to us by Yorkville specifically for use in this prospectus or, if such indemnity is unavailable,
to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC
this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.

We estimate that the total